Physician

Robert Roy Byrne, M.D.

According to 2025 Medicare claims, Robert Byrne, M.D. (NPI: 1902805765) practices urology in the Athens-Clarke County, GA market, with the plurality of this provider's patient population coming from Clarke, GA. This provider's primary affiliated billing organization is ATHENS AREA UROLOGY, PC (NPI: 1578803755; TIN: 462091392) and primary practice location at 30677-7712.

Byrne's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,104 traditional Medicare patients, billed 41,546 HCPCS/CPT codes, and received $563,221 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,582 prescription claims across 909 beneficiaries totaling $3,137,140 in drug costs, led by Xtandi (Enzalutamide). DME data shows 173 claims. Open Payments data shows 42 records totaling $1,092. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $515,244 and ending at $563,221. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $385,164 to $3,137,140. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,220 and ending at $874.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	846	9,387	$515,244
2016	949	11,269	$273,169
2017	1,319	19,113	$739,119
2018	1,334	17,733	$535,815
2019	1,333	26,897	$879,393
2020	1,242	23,712	$419,026
2021	1,236	34,873	$567,686
2022	1,110	34,283	$325,985
2023	1,086	40,298	$481,073
2024	1,104	41,546	$563,221

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	766	4,485	$385,164
2016	970	4,915	$555,194
2017	1,244	6,687	$857,392
2018	1,232	6,813	$987,457
2019	1,223	6,563	$1,192,183
2020	1,035	4,781	$1,073,011
2021	779	2,910	$971,532
2022	748	2,786	$1,178,489
2023	787	2,829	$1,230,987
2024	909	3,582	$3,137,140

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	107	$39,023
2016	28	208	$46,049
2017	32	271	$71,244
2018	15	148	$66,384
2019	11	140	$51,524
2020	N/R	87	$33,718
2021	12	150	$48,537
2022	14	181	$68,474
2023	20	181	$65,628
2024	24	173	$94,305

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	657	976	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	490	619	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	655	933	$12
81001	Manual urinalysis test with examination using microscope, automated	489	800	$3
81003	Automated urinalysis test	570	913	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	102	3,060	$1,247,934
Erleada	Apalutamide	49	1,550	$705,021
Nubeqa	Darolutamide	42	1,260	$567,156
Orgovyx	Relugolix	111	3,310	$285,720
Gemtesa	Vibegron	160	7,753	$123,257

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	11	50	$48,033
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	13	98	$26,766
A4353	Intermittent urinary catheter, with insertion supplies	N	N/R	11	$19,270
A4332	Lubricant, individual sterile packet, each	N	N/R	14	$236

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$1,092	Teleflex LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Roy Byrne, M.D.?

Tedicare shows public-source Medicare data for Robert Roy Byrne, M.D. (NPI 1902805765), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Roy Byrne, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Roy Byrne, M.D.?

Robert Roy Byrne, M.D. is linked to ATHENS AREA UROLOGY, PC (billing NPI 1578803755) in the available physician profile data.

Does Robert Roy Byrne, M.D. have Open Payments data?

Robert Roy Byrne, M.D. has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.